From Diabetes In Control.com
"We made a lot of assumptions and jumped to a lot of conclusions that the markers of cardiovascular disease and treatments for prevention of cardiovascular diseases will be the same in type 1 — and that just may not be the case," said Fernando Ovalle, MD, director of the Comprehensive Diabetes Center of the University of Alabama at Birmingham. "This could potentially change the perspective on how we see the use of statins and the assessment of cardiovascular risk in general."
